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It was observed almost thirty years ago that,
following an intravenous or interaperitoneal in-
jection of egg white, rats develop an acute swell-
ing of the "acral regions" particularly the paws,
snout, ears and tail. Histologically, the affected
parts exhibit an acute serous inflammation simi-
lar to that seen in certain anaphylactic reactions,
but since the egg-white-induced changes occur
after the first injection (without previous sen-
sitization) the response was named "anaphy-
lactoid inflammation" (1).
Subsequent investigations showed this lesion
to be associated with mast-cell degranulation and
a release of histamine and serotonin in the
anaphylactoid shock organs. This whole reaction
can be duplicated by a number of other mast-
cell dischargers (e.g., dextran, dextrin, com-
pound 48/80, polymyxin) and inhibited by anti-
histaminics and serotonin antagonists; hence, it
is generally assumed that the discharge of bio-
logic amines from tissue mast cells plays an im-
portant role in the pathogenesis of anaphylactoid
inflammation. The voluminous literature deal-
ing with this subject has been reviewed else-
where (2,3).
Independently of these studies, it has been
found more recently that a thrombohemorrhagic
phenomenon (THP) can be elicited in various
species, for example in the rat, by a dual treat-
ment: 1. Systemic administration of various
"sensitizers" (in most instances metals or poly-
saccharides) which produce a general thrombo-
hemorrhagic diathesis; 2. topical or systemic
treatment with certain "challengers" (e.g.,
catecholamines, serotonin, vasopressin or mast-
cell dischargers) which make this latent disease-
proneness manifest and determine the localiza-
tion of the resulting thrombohemorrhagic
lesions (4).
Certain seaweed polysaccharides such as agars,
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carrageenans and alginates are especially potent
sensitizers for the THP but they produce no
anaphylactoid inflammation. On the other hand,
if rats are given agar in combination with such
mast-cell dischargers as dextran, dextrin or egg
white, a type of anaphylactoid purpura results
in which the acute swelling of the acral regions
is associated with multiple hemorrhages and
microthromboses (5); evidently anaphylactoid
inflammation and the THP can occur in com-
bination.
Curiously, one agar preparation was found
to elicit a pronounced anaphylactoid purpura
by itself while others were inactive in this re-
spect even when given in combination with nor-
epinephrine (6). However, combined treatment
with some inactive agars and norepinephrine
often produced severe THP-lesions in internal
organs, particularly the kidney, lung and intes-
tine.
A singular type of anaphylactoid purpura,
limited to the posterior part of the body, has
been produced in rats by combinations of THP-
sensitizers, anaphylactoid agents and norepi-
nephrine. The most effective combination among
those tested was Thorotrast + tannic acid +
norepinephrine. In rats thus treated, intense
mast-cell discharge was observed in the affected
parts, but since Thorotrast (by virtue of its
dextrin content) is a potent mast-cell discharger
in itself, no special attention was given to the
possible mast-cell degranulating action of the
catecholamine (7) in this drug combination.
Here, we shall report upon experiments show-
ing that an anaphylactoid purpura with pro-
nounced mast-cell discharge in the shock organs
can be produced by combined treatment with
certain polysaccharides and epinephrine. Ap-
parently, under these circumstances, the cate-
cholamincs can assume mast-cell-degranulating
properties.
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MATERIALS AND METHODS
For all our experiments we used female Sprague-
Dawley rats with a mean body weight of 100 gm
(range 90—110 gm) which were treated as indicated
in Tables I—TV.
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The following 17 agar preparations (described
as specified by the manufacturers) were tested for
possible sensitizing effect:
I. Agar Powder U.S.P., AC 260 lot No. 460626
(Anechemia Chemicals Ltd., Montreal, Canada).
II. Bacto-Agar granular for microbiological use,
lot No. 0140-01 (Difco Laboratories, Detroit,
Mich., U.S.A.).
III. Agar-Agar U.S.P., lot No. 365 (Brickman
Co., Montreal, Canada).
IV. B.D.H. Agar U.S.P. for bacteriological use,
lot No. 27459 (British Drug Houses Ltd., Toronto,
Canada).
V. Noble Agar (Difco).
VI. Agar, bacteriological grade, lot No. 71-1318
(Fisher Scientific Co., Fair Lawn, N. J., U.S.A.).
VII. French Agarose (Industrie Biologique
Francaise, S.A., Gennevilliers, Seine, France).
VIII. Kobe Agar U.S.P. for bacteriological use,
lot No. 6642 (Nutritional Biochemicals Corp.,
distributed by Brickman Co., Montreal, Canada).
IX. M.CB. Agar Powder U.S.P. for bacteriologi-
cal use, lot No. 7745 (Matheson, Coleman & Bell,
Norwood, Cincinnatti, Ohio, U.S.A.).
X. Saskatoon Agarose (kindly supplied by
Professor L. Jaques, University of Saskatchewan,
Saskatoon, Canada).
XI. Agar Agar KBH-80, Danish (Prescott &
Co. Ltd., Montreal, Canada).
XII. Agar Agar Clara, Spanish (Prescott &
Co.).
XIII. Agar Agar No. 1, Japanese (Prescott &
Co.).
XIV. Agar Agar granular, lot No. 755 (Harleco,
distributed by Canadian Laboratory Supplies
Limited, Montreal, Canada).
XV. Agar granulated (PH), lot No. 2121 (Mann
Research Laboratories Inc., New York 6, N. Y.,
U.S.A.).
XVI. Agar USP granulated, lot No. 54344
(General Biochemicals, Chagrin Falls, Ohio,
U.S.A.).
XVII. Bact Agar (Japanese Nutritional Chemi-
cal C., Tokyo, Japan).
Many of the agar preparations manufactured
in large amounts for industrial purposes are dis-
tributed by various companies under different
labels and the original source of individual lots
is often difficult to trace. Hence, some of the
preparations collected from different distributors
may actually be identical. However, this does
not vitiate our purpose, namely the identification
of lots possessing the desired toxicologic activity.
In addition to the agars we used as sensitizers
Carrageenan. (0), the ordinary impure carrageenan
of the market, two preparations of Carrageenan
(K), or kappa carrageenan (one partially and one
highly purified) as well as a highly purified sample
of Carrageenan (x) or lambda carrageenan (all
kindly supplied by Dr. S. D. Upham of Marine
Colloids Inc., New York, U.S.A.).
The individual dose of all agar and carrageenan
preparations was administered in 1 ml of distilled
water into the jugular vein under light ether
anesthesia.
Epinephrine (Adrenaline bitartrate, Brickman
& Co., Montreal, Canada) was used as a challen-
ger, invariably at the dose of 400 g injected in
02 ml of water subcutaneously under the skin of
the back, immediately after treatment with the
sensitizer.
Since the THP-lesions are fully developed
within a day, the experiments were terminated
after 24 hrs. by killing the survivors with chloro-
form. Only in the second experiment—designed
to study the histogenesis of the lesions—did we
sacrifice the rats at different times between 5 mm.
and 24 hrs. after challenge, as indicated in Table
II. The organs were inspected with a binocular
dissecting loupe and the intensity of the thrombo-
hemorrhagic lesions was estimated in terms of an
arbitrary scale in which 0 = no lesion, 1 = just
visible, 2 = moderate, 3 = most pronounced le-
sions, as previously described (4, 8). The means of
these lesions are indicated in the Tables together
with the percentual mortality rates.
Immediately after autopsy, specimens of the
organs were taken for histologic study with the
PAS-technic for general orientation, Azure-A for
the demonstration of metachromasia and the
"multi-purpose polychrome technic" for the stain-
ing of erythrocytes and fibrin (7, 8).
RE SULTS
Production of anaphylactoid purpura by
epinephrine after sensitization with various agar
preparations (Table I) .—In the first experi-
ment, we wanted to compare the ability of
various agar preparations to sensitize for the
production of an anaphylactoid purpura by epi-
nephrine. Seventeen preparations were tested
(on 34 groups of 10 rats each) always at the
dose of 0.5 mg given intravenously with or
without simultaneous challenge by 400 tg of
epinephrine given subcutaneously.
Neither Agar I (Group 1) nor Agar XI
(Group 3) produced any significant lesions by
themselves at the dosage given, while in com-
bination with epinephrine both these prepara-
tions elicited severe thrombohemorrhagic lesions
in the acral portions of the body, particularly
the paws, snout and tail (Fig. 1). Only occa-
sional minor changes were noted in the internal
organs and there was no mortality. However,
ancillary experiments (not reported here in de-
tail) have shown that, at the dose of 5 mg, both
Agar I and Agar XI can produce similar though
less constant and less severe, anaphylactoid
purpuric lesions by themselves. At this dose
level THP-changes are also evident in the kid-
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TABLE I
Production of anaphylactoid purpura by epineph-
rine after sensitization with various
agar preparations
Group Treatment*
Thrombohemorrhagic
lesions (Scale: 0—3)
MOrtal.
Paws Tail Heart
1
2
3
4
5—19
20—34
Agarl
Agar I +
Epineph-
rine
AgarXI
AgarXI+
Epineph-
rine
15 other
Agar
prepara-
tions
As Gr. 5—19
+ Epi-
nephrine
0
3.0
0
3.0
0
0
0
1.4
0.2
2.6
0
0
0
0.2
0
0
0
0
0.4
0.4
0
0
0
0
0
0
0
0
0
0
* For details see text.
ney, heart and other internal organs, especially
in the event of simultaneous treatment with epi-
nephrine.
Since none of the other fifteen agar prepara-
tions produced any evidence of anaphylactoid
purpura, either by themselves (Groups 5-19)
or in combination with epinephrine (Groups
20—34); these experiments are lumped together
in Table I.
Histologic examination of the lesions obtained
by Agar I and Agar XI in combination with
epinephrine showed them to be characterized
primarily by mast-cell discharge, thromboses in
the microcirculation and diffuse interstitial
hemorrhages. A second experiment was there-
fore performed with the highly active Agar XI
to determine the time sequence in the develop-
ment of these changes which may throw some
light upon their histogenesis.
Histo genesis of anaphylactoid purpura pro-
duced by Agar XI + epinephrine (Table II).—
This experiment consisted of eleven groups of
4 rats each. We used 0.5 ml of Agar XI intra-
venously as a sensitizer, and 400 tg of epineph-
rine subcutaneously as a challenger, in the
manner described under "Materials and Meth-
ods". Five of these groups were challenged im-
mediately after sensitization and then sacrificed
respectively 5 mm., 15 mm., 1 hr., 7 hrs. and
24 hrs. later. Five additional groups were killed
at the same time intervals after sensitization
without challenge. The last group was only chal-
lenged in the usual manner and killed after 7
hrs., that is, when the lesions elicited by com-
bined sensitization and challenge were well de-
veloped. No noteworthy histologic change was
seen in the paws of the rats given Agar XI or
epinephrine alone; hence, Table II deals only
with the rats killed at various intervals after
combined treatment with both these agents.
Since, under our experimental conditions,
anaphylactoid purpura usually affected the hind
paws most regularly and severely, these were
taken as indicators of the reaction as a whole.
The left paw of each animal was fixed and
simultaneously decalcified in Susa-solution satu-
rated with picric acid for subsequent staining
with the multi-purpose polychrome technic and
the PAS-procedure (7). The right paw was fixed
in alcohol formol (1 part of 10% neutral forma-
lin, 4 parts of absolute alcohol) and then its soft
tissues were carefully dissected from the bones
(to avoid the need for decalcification) and
stained with Azure-A to demonstrate the meta-
chromasia of the mast-cell granules (8).
After 5 mm. (Group 1), no significant change
was detectable (Fig. 2).
After 15 mm. (Group 2), macroscopic inspec-
tion showed only mild hyperemia but histologi-
cally a few mast cells, especially those situated
near small blood vessels, were seen to have
discharged their granules. Occasional micro-
thrombi (consisting of platelets, fibrin threads
and erythrocytes) occurred in the adjacent yen-
ules. Here, as in all subsequent groups, the azure
stain merely revealed loss of metachromasia and
swelling in discharged granules. The multi-pur-
pose polychrome stain, on the other hand, con-
firmed the previously observed fact (7) that the
intracellular mast-cell granules are very small
and either light blue or bluish purple while after
discharge they are not only greatly swollen
but immediately assume a red color. This sud-
den change in stain affinity suggests that some
rapid chemical or physical changes occur in the
mast-cell granules upon discharge from the cell
body into the surrounding connective-tissue
spaces. Clumps of similarly staining red granules
were also seen in and around the microthrombi
within vessels; yet, on the basis of histologic
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Fie. 1. Gross oppearance of experimentel anaphylactoid purpura.—Left: Fully developed
lesions in the paws and snout of a rat 24 hours after treatment with Agar 11 + epinephrine.
Right: Absence of lesions in a rat given Agar I alone. (Incision on neck was made for intra-
jugular injection.)
observations alone, it is impossible to determine
whether these intravascular accumulations are
actually derived from the granules of the pen-
vascular mast cells.
After 1 hr. (Group 3), macroscopically, the
paws were swollen and pink but did not yet show
definite evidence of hemorrhage. Histologic ex-
amination showed that mast-cell discharge con-
tinued hut was still of moderate intensity.
Thrombi now appeared also in larger veins and
pctcchial hemorrhages were seen in the vicinity
of the vessels. The perivascular lymphatics were
greatly dilated and filled with fluid and a granu-
lar material. The latter did not stain meta-
chromatically with azure, but assumed a red
color (similar to that of the discharged mast-cell
granules) in multi-purpose polychromc prepa-
rations.
After 7 hrs. (Group 4), the swelling of the paw
was virtually unchanged but now massive hem-
orrhages infiltrated its soft tissues. Histologi-
cally, we noted hemorrhagic infiltration of all
-
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TABLE TI
Histogenesis of anaphylactoid purpura produced by
Agar XI plus epinephrine
Macroscopic
lrsioos
Group puration*
(Scale: 0—3)
Pciocipal microscopic
Swell-
iog ¶rhagc
1 5mm. 0 0 None
2 15 mm. 0 0 Beginning mast cell
(MC) degranula-
tion. Few micro-
thrombi in small
venules.
3 1 hr. 1.0 0 MC discharge con-
tinues. Thrombi
appear in larger
veins. Beginning
hemorrhage. Dila-
tation of lym-
phatics.
4 7 hrs. 1.0 3.0 Hemorrhage, throm-
bosis and MC-dis-
charge nearly
maximal.
5 24 hrs. 2.0 2.5 Changes similar but
more severe than
after 7 hrs. Oc-
casional thrombi
in small arteries.
* Time elapsed after treatment with 0.5 mg of
Agar XI and 400 jg of epinephrine.
the soft tissues. Thrombi were virtually ubiqui-
tous in the small and medium-sized veins, though
exceptional in arterioles. With the multi-purpose
polychrome technique, the intravascular erythro-
cytes stained deep red and were closely packed—
forming so-called "erythrocyte agglutination
thrombi"—even in vessels in which true fibrin
and platelet thrombi were not detectable. The
shed blood began to disintegrate so that the
erythrocytes in the connective tissue now stained
only a pale pink and gradually lost their con-
tours. Often apparently normal mast cells with
small blue granules were found intermixed with
clumps of swollen red granules, presumably dis-
integrating mast cells. In many regions, the en-
tire connective tissue was diffusely infiltrated
with these swollen red mast-cell granules; the
number of intravascular clumps of similar gran-
ules also increased. There was intense vascular
dilatation and hemorrhage underneath the pen-
osteum of the bones and in the synovia of the
small joints (Figs. 2 and 3).
After 24 hrs. (Group 5), the changes were
similar in character though more severe than
those seen after 7 hrs. A few additional thrombi
appeared in small arteries (Fig. 3).
In summary, it may be said that experimental
anaphylactoid purpura begins with the degranu-
lation of the regional mast cells, yet almost
simultaneously microthrombi appear first in the
smallest then in the medium-sized venules, but
only exceptionally in small arteries. The lym-
phatics are greatly dilated with edema fluid and
some granular material. It is impossible to as-
certain, however, whether the mast-cell dis-
charge is the cause or the consequence of the
thrombohcmorrhagic reaction. It also remains
to be seen whether the granule clumps appear-
ing in the lumens of veins and lymphatics are
derived from mast cells, even though they show
a similar staining behavior. The response is vir-
tually fully developed after 7 hrs. and is then
associated with massive subperiosteal and syno-
vial hemorrhages. After 24 hrs., these changes
are only slightly more pronounced.
Preliminary experiments with a large number
of other polysaccharides (including alginates,
fucoidin, dextran, dextrin, etc.) yielded com-
pletely negative results in that none of these
compounds, given alone or in combination with
epinephrine, produced the slightest trace of an
anaphylactoid purpura at any tolerable dose
level. Hence, these tests will not be described
here in detail. On the other hand, positive re-
sults were obtained with various carrageenan
preparations, though only when given in com-
bination with epinephrine. Even then the re-
sults were much more variable when carrageenan
was used as a sensitizer than when Agar I or
Agar XI were employed. It was thought that at
least one of the factors responsible for this
variability might be the phenomenon of "over-
sensitization". It had been found previously that
certain other forms of THPs—for example that
due to induced hypersensitivity to cold—can be
elicited by small but not by large doses of car-
rageenan (9). Hence, we wished to determine
whether over-sensitization by carrageenan can
also interfere with the production of an anaphy-
lactoid purpura by epinephrine.
Production of anaphylactoid purpura by epi-
nephrine after sensitization with Corrageenan
(0) and its prevention by "over-sensitization"
Fm. 2. Development of lesions in the hind paws of a rat given Agar XI + epinephrine.—
A: Altar 5 minutes. Mast cells virtually intact (Multipurpose polychrome or "MP" stain
X 377). B: 7th hour. Most of the mast cells (arrows pointing to left) have discharged their
granules though some (arrows pointing to right) retain essentially normal appearance. Blood
clot (large oblique arrow) inside a blood vessel (MP >< 377). C: Higher magnification of es-
sentially normal mast cells from Fig. A (MP X 820). D: Higher magnification of discharged
mast cells from Fig. B. Only two mast cells (near upper right corner) retain essentially nor-
mal appearance, others are disintegrating and their free granules diffusely infiltrate the sur-
rounding tissue (MP )< 820).
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Fsa. 3. Development of lesions in the hind paws of a rat given Agar XI + epinephrine
(cont'd).—A: 7th hour. Several large veins in periarticular connective tissue are packed with
erythroeytes; some of them show beginning thrombus formation through development of
fibrin clots. The surrounding tissue is diffusely infiltrated with partially lysed erythrocytes(MP )< 92). B: 7th hour. Thrombus formation at the point of union of three small veins
(outlined by pairs of facing arrows). Coagulum, consisting mainly of fibrin threads, leuko-
cytes and platelets, contracts away from endothelium at several places (PAS X 92). C: 7th
hour. Small venule packed with erythrocytes ("erythrocyte conglutination thrombus"). Some
of the perivascular mast cells are intact, others have discharged their granules (MP >< 462).
D: 24th hour. Intense hyperemia, edema and inflammatory infiltration in the synovial
membrane of a small tarsal joint. The largest blood vessel (arrow) contains a thrombus(PAS X 92). B: 24th hour. Massive hemorrhage (between arrows) underneath the perios-
teum of a tarsal bone (MP >< 92).
'
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(Table III) .—Four groups of 10 rats each were
sensitized with Carrageenan (0) at the dose
levels of 1 mg and 5 mg respectively, with and
without challenge by epinephrine, as shown in
Table III. In itself Carrageenan (0) produced
no evident lesion at either of these dose levels
(Groups 1 and 3). Conversely, after epinephrine
challenge, the rats receiving 1 mg of the sen-
sitizer showed a pronounced anaphylactoid pur-
pura (Group 2) whereas those given 5 mg of the
sensitizer remained virtually normal despite
simultaneous treatment with the same amount of
the challenger (Group 4). Thus, the curious phe-
nomenon of over-sensitization can undoubtedly
interfere with the production of anaphylactoid
purpura by carrageenan + epinephrine.
The question arose whether purified Carra-
geenan (K) + epinephrine can also elicit an
anaphylactoid purpura and whether, here again,
raising the dose of the sensitizer above a certain
optimal level would lead to over-sensitization. To
verify these points an additional experiment was
performed with graded doses of two preparations
of Carrageenan (K).
Production of anaphylactoid purpura by epi-
nephrine after sensitization with Carrageenan
(K) and its prevention by "over-sensitization"
(Table IV) .—Five groups of rats were treated
with different doses of a partially purified Car-
rageenan (K)-preparation ("Gelcarin HWG");
another 5 groups received a highly purified speci-
men of Carrageenan (K). Except for one control
group in each series, all animals were simul-
taneously challenged by 400 tg of epinephrine
as indicated in Table IV.
In themselves, neither of these carrageenan
preparations produced any trace of thrombo-
hemorrhagic lesion in the paws (Groups 1 and
6), although occasionally, they did elicit hemor-
rhagic necrosis of the tail. It must be pointed out,
however, that isolated necrosis of the tail, with
or without hemorrhage, can be produced by a
variety of agents (e.g., ergot derivatives) and is
not characteristic of anaphylactoid purpura. In
any event this tail necrosis was variable and
relatively independent of the dose of Car-
rageenan (K) in the individual groups.
On the other hand, the true anaphylactoid
purpuric lesions in the paws proved to be defi-
nitely subject to "over-sensitization". They were
quite evident after administration of as little as
300 g of either the partially or the highly pun-
TABLE III
Production of anaphylactoid purpura by epineph-
rine after sensitization with carraqeenan (0)
and its prevention by "over-sensitization"
Group
Treatment Thrombohemorrhagiclesions (Scale: 0—3)
Carra- Epi-
IortaI-
ity (%)
geenan(0)
(mg)
neph-
rine
(pg)
Paws Tail Heart
1 1 0 0 0 0 0 0
2 1 400 3.0 2.0 0 0.2 20
3 5 0 0 0 0 0 0
4 5 400 0.3 0 0 0 0
TABLE IV
Production of anaphylactoid purpura by epinph-
rine after sensization with carrageenan (ic)
and its prevention by "over-sensitization".
* Groups 1—5 received a partially purified,
Groups 6—10 a highly purified preparation Carra-
geenan (e) as explained in "Materials & Methods".
fled preparation of Carrageenan (K) (Groups 5
and 10), and negligible (Group 2) or even totally
absent (Group 7) in the rats given 5 mg of the
same sensitizers. As in the preceding experiment,
neither of the carrageenan preparations pro-
duced noteworthy thrombohemorrhagic lesions
in the kidney or heart.
Failure to produce anaphylactoid purpura by
epinephrine after pre-treatment with Carra-
geenan (A) .—The ordinary carrageenan prepa-
rations contain both the kappa and the lambda
variant; hence, a highly purified preparation of
Treatment ThrombohemorrhagicLesions (Scale: 0—3)
Paws Tail
Group
1
2
3
4
5
6
7
8
9
10
Carra-
geenan
(mg)
1
5
1
0.5
0.3
1
5
1
0.5
0.3
Epi-
neph-
rine
(jig)
0
400
400
400
400
0
400
400
400
400
0
0.4
2.2
2.1
1.7
0
0
1.8
2.0
2.8
Kid-
ney
0
0.2
0.2
0
0
0
0
0.4
0
0
0.5
1.6
1.8
1.7
2.5
1.0
2.2
0.4
2.4
2.8
Heart
0
0.5
0.2
0.2
0.4
0
0
0
0
0
iviortal-
ity (%)
0
10
20
10
0
0
0
30
0
0
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the latter fraction was tested under the condi-
tions of the preceding experiment. It became
evident, however, that carrageenan (A) failed to
produce an anaphylactoid purpura either when
given by itself or in combination with epi-
nephrine at all dose levels tested between 0.3 and
S mg; hence, it would be redundant to tabulate
these findings.
DISCUSSION
All known forms of anaphylactoid inflamma-
tion are associated with mast-cell degranulation
in the affected regions. Yet, earlier work showed
that epinephrine fails to induce granule dis-
charge in the peritoneal mast cells of the rat (16)
and now we have learned that the same is true
of the mast cells in the anaphylactoid shock or-
gans (except if certain pclysaccharides are used
as sensitizers).
Several investigators have found furthermore
that epinephrine actually inhibits the ordinary
anaphylactoid inflammation that can be pro-
duced by various technics in the rat (10-44). A
calcifying type of anaphylactoid reaction can be
produced by combined treatment with dihydro-
tachysterol and ferric dextrin through the proc-
ess of calciphylaxis (8). This variant is also in-
hibited by epinephrine (15).
In view of these findings, it was unexpected to
note, in the course of the work reported in this
paper that, following pre-treatment with certain
agar or carrageenan preparations, epinephrine
produces a thrombohemorrhagic variant of ana-
phylactoid inflammation. This reaction affects
the acral regions and resembles certain types of
anaphylactoid purpura, both in its cutaneous
localization and in its histologic structure. Ap-
parently, here, we are dealing with another ex-
ample of the "conditional hormone actions" such
as are particularly obvious among corticoids
(17).
The mast-cell discharge induced by epineph-
rine after sensitization with suitable polysac—
charides, is associated with multiple thromboses
in the microcirculation and intense hemorrhage
into the surrounding connective tissue. Particu-
larly massive bleeding occurs in the pericsteum
and the synovial membranes of the bones and
joints, of the feet. Serial histologic examinations
of the affected parts revealed that mast-cell de-
granulation begins as soon as 15 mm. after treat-
ment, although several hours are needed for
the full development of the characteristic throm-
bohemorrhagic lesions. This sequence of events
suggests that mast-cell products (e.g., hista-
mine, serotonin, heparin) may play a role in the
pathogenesis of the experimental anaphylactoid
purpura. Yet, such a causal relationship is far
from being proven. It is possible that the light
microscope fails to reveal the earliest structural
or chemical changes; hence, mast-cell discharge
may merely be an associated but causally unim-
portant event in the formation of the thrombo-
hemorrhagic response.
All forms of the THP, in which epinephrine is
used as the challenger, can be prevented by such
antiadrenergic agents as dibenzyline (4). How-
ever, here, the response is blocked at the stage
preceding the mast-cell discharge; hence, this
finding sheds no light on the problem under dis-
cussion. Further work is necessary to show
whether inhibitors of mast-cell products (e.g.,
antihistaminics, antiserotonins, antiheparins)
can prevent the anaphylactoid form of THP.
Among numerous agar preparations, only two
proved to be effective in sensitizing the rat for
the production of an anaphylactoid purpura by
epinephrine. Therefore, it is reasonable to as-
sume that this effect is not due to agar itself
but to some contaminant present only in some
preparations or that it depends upon a proper
proportion of the two principal components of
agar: agarose and agaropectin. It is, perhaps,
significant that two highly purified specimens of
agarose (our "Agar VII', and "Agar X") failed
to sensitize for this action of epinephrine.
While the two active agar preparations of our
series gave very consistent results, the car-
rageenans were much less regularly effective. One
source of this variability could be traced to the
phenomenon of "over-sensitization". Under con-
ditions under which small doses of carrageenans
sensitized for the production of severe anaphy-
lactoid purpura, large doses were ineffective.
Such over-sensitization had already been noted
in other forms of the THP and its possible ex-
planation has been discussed elsewhere (9). Yet,
even under optimal conditions of dosage, car-
rageenans are not as consistently effective as
suitable agar preparations; hence, presumably
there are additional factors which may interfere
with this response.
Finally, it should be emphasized that, although
the anaphylactoid THP greatly resembles cer-
tain forms of anaphylactoid purpura of man, the
former can merely be regarded as a convenient
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experimental model of the latter; we have no
proof of any fundamental pathogenetic relation-
ship between the experimental and the clinical
disease.
SUMMARY
After a brief outline of anaphylactoid inflam-
mation and of the thrombohemorrhagic phe-
nomenon (THP), experiments are described
which show that, in t-he rat, it is possible to
produce a combination of these two phenomena.
This type of lesion is elicited by epinephrine
given in combination with certain agar or car-
rageenan preparations. It manifests itself as an
anaphylactoid purpura affecting the acral re-
gions, particularly the paws, snout and tail.
The anaphylactoid THP—like ordinary ana-
phylactoid inflammation or its calcifying variant
elicited by calciphylaxis—is associated with in-
tense mast-cell degranulation in the shock or-
gans. This is noteworthy since epinephrine does
not cause mast-cell degranulation in itself, in-
deed it actually inhibits the discharge of mast
cells that accompanies other forms of anaphy-
lactoid reactions.
The possible relationship between the experi-
mental anaphylactoid THP and the anaphylac-
toid purpura of man remains to be elucidated.
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